ArsenalBio | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

14 February 2024

Venture cash funds first human trials

Private company trial initiations stand out in the latest week’s disclosures.

Deals

31 January 2024

Pfizer shuffles its deck post-Seagen

The group’s B7-H4-targeting bispecific is out, in favour of Seagen’s ADC.

Subscribe to ArsenalBio